| Source: |
| Type: |
| 6-Iodolactone - 6-Iodo-5-Hydroxy-8,11,14-Eicosatrienoic Acid δ-Lactone Alternative Names: 6-Iodolactone, 6IL, 6-iodo-5-hydroxy-8,11,14-eicosatrienoic acid δ-lactone Type: Iodolipid / iodinated arachidonic-acid derivative / bioactive lipid metabolite Formation: 6-IL is formed by iodination of arachidonic acid and has been detected in thyroid and mammary tissues following iodine exposure. Molecular iodine can increase 6-IL formation in tumor tissue containing elevated arachidonic acid. Function: 6-Iodolactone is a bioactive iodolipid that mediates part of the antiproliferative and apoptotic effects of iodine. It acts as an activator of PPARγ and can regulate proliferation, differentiation, mitochondrial apoptosis, migration, and tumor-associated signaling. Cancer: Preclinical studies demonstrate inhibition of tumor-cell proliferation and migration and induction of apoptosis. 6-IL activates PPARγ, and inhibition or knockdown of PPARγ substantially reduces its antiproliferative and pro-apoptotic effects. Antitumor activity has been demonstrated particularly in breast, thyroid, and prostate cancer models. |
| Normal Healthy |
| 7678- | iod, | Signaling pathways involved in the antiproliferative effect of molecular iodine in normal and tumoral breast cells: evidence that 6-iodolactone mediates apoptotic effects |
| - | in-vitro, | Nor, | MCF12A | - | in-vitro, | BC, | MCF7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:1680 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid